Clin2
NCT07295717Worth exploringRecruiting

ALN-4285 safety study in healthy adults

Healthy Volunteers

This study tests a new medicine called ALN-4285 in healthy adults to see how safe it is and how the body processes it. It may help find a new treatment for certain conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
76 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Your body mass index (BMI) must be between 18 and 30.
  • Your heart tracing (ECG) must be normal.
  • Your liver enzymes (ALT and AST) and bilirubin must be within normal limits.
  • Your blood pressure must be below 140/90.
  • Your kidney function (eGFR) must be above 90 mL/min.
  • You cannot have taken an experimental drug in the last 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07535606Recruiting· Phase 1
Safety Study of ALN-4915 in Healthy Adults

This is an early-stage study testing a new investigational medicine called ALN-4915 in healthy volunteers. Researchers want to learn if it is safe and how the body processes it.

London
NCT05648214Recruiting· Phase 1/Phase 2
Testing a new liver medicine in people with fatty liver

This early-phase study tests whether ALN-PNP is safe and well tolerated, first in healthy adults and then in adults with MASLD (fatty liver disease). If you have MASLD, it may help researchers learn whether this medicine is a promising option for treating liver fat buildup.

Glendale, California
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT06995326Not yet recruiting· Phase 1
Study of an experimental drug SGB-3383 in healthy volunteers

This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.

NCT07271693Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.

Christchurch
NCT07352423Recruiting· Phase 1
Safety study of ALXN2230 in healthy volunteers

This trial tests the safety and how the body handles a new drug called ALXN2230 in healthy people. It helps find the right dose and checks for side effects.

London

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.